Company takes over vaccine business in Denmark

(From left) Statens Serum Institute chief executive officer Prof Mads Melbye, AJ Pharma Group chairman Sheikh Abdulaziz Hamad Al Jomaih, Dr Tabassum Khan and AJ Vaccines chief executive officer Klaus Hermansen.

AJ PHARMA Group has successfully completed its first global vaccine business acquisition in Denmark.

The 100% acquisition creates an independent vaccines production business from the Danish Government-owned Statens Serum Institut (SSI).